Zacks Investment Research upgraded shares of Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) from a sell rating to a hold rating in a research report released on Tuesday morning, Zacks.com reports. According to Zacks, “Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a […]
ARK Investment Management LLC cut its position in shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Rating) by 3.7% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 49,259 shares of the company’s stock after selling 1,908 shares during the quarter. ARK Investment Management LLC’s holdings in Taro Pharmaceutical Industries were worth $2,468,000 […]
Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Rating) shares reached a new 52-week low during trading on Wednesday . The stock traded as low as $43.22 and last traded at $43.22, with a volume of 7 shares traded. The stock had previously closed at $43.42. Several research analysts have recently commented on the company. Zacks […]